Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and uridine diphosphate glucuronic acid

pyrroles has been researched along with uridine diphosphate glucuronic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baillie, TA; Fang, X; Lin, JH; Ma, B; Pearson, PG; Prueksaritanont, T; Qiu, Y; Subramanian, R1
Bauman, JN; Davis, JA; Goosen, TC; Hurst, SI; Loi, CM; Williams, JA; Yu, C1
Christopher, LJ; Hong, H; Humphreys, WG; Iyer, RA; Ma, L; Su, H; Yao, M1

Other Studies

3 other study(ies) available for pyrroles and uridine diphosphate glucuronic acid

ArticleYear
Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.
    Drug metabolism and disposition: the biological fate of chemicals, 2002, Volume: 30, Issue:5

    Topics: Animals; Atorvastatin; Bile; Dogs; Glucuronides; Glucuronosyltransferase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Magnetic Resonance Spectroscopy; Microsomes, Liver; Protein Isoforms; Pyridines; Pyrroles; Rats; Recombinant Proteins; Simvastatin; Uridine Diphosphate Glucuronic Acid

2002
Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:8

    Topics: Anticholesteremic Agents; Area Under Curve; Atorvastatin; Catalysis; Drug Interactions; Fenofibrate; Gemfibrozil; Glucuronic Acid; Glucuronides; Glucuronosyltransferase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lactones; Microsomes, Liver; Models, Biological; Molecular Structure; Pyrroles; Recombinant Proteins; Tandem Mass Spectrometry; Uridine Diphosphate Glucuronic Acid

2007
In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:9

    Topics: Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; ErbB Receptors; Glucuronosyltransferase; Hepatocytes; Humans; Microsomes, Liver; NADP; Piperidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Triazines; Uridine Diphosphate Glucuronic Acid

2011